7 generic drugs delisted from health insurance

Published: 2009-04-02 06:59:00

Updated: 2009-04-02 06:59:00

The Ministry of Health, Welfare and Family Affairs announced on March 30 that seven generic drugs must be taken off the market due to lack of economic effectiveness.

Hyperlipemia drugs produced by Young Pharm, Otsuka Korea, Korea Core, Korea Wales, Korea Meditec, Sam-A and Korea Pharm proved t...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK